Elevance Health, Inc. (ELV)

Elevance Health Stock Forecast

Stock Price Forecast

The 18 analysts that cover Elevance Health stock have a consensus rating of "Buy" and an average price target of $381.5, which forecasts a 20.27% increase in the stock price over the next year. The lowest target is $297 and the highest is $485.

Price Target: $381.5 (+20.27%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$297	$381.5	$391	$485
Change	-6.37%	+20.27%	+23.26%	+52.90%

Analyst Ratings

The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	4	4	4	4
Buy	6	6	7	7	7	7
Hold	6	7	7	7	7	8
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	17	18	18	18	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Elizabeth Anderson Evercore ISI Group	Evercore ISI Group	Hold Initiates $345	Hold	Initiates	$345	+8.76%	Apr 8, 2026
Ann Hynes Mizuho	Mizuho	Buy Maintains $413 → $350	Buy	Maintains	$413 → $350	+10.34%	Mar 11, 2026
Lisa Gill JP Morgan	JP Morgan	Buy Maintains $394 → $397	Buy	Maintains	$394 → $397	+25.15%	Feb 2, 2026
David Macdonald Truist Securities	Truist Securities	Strong Buy Maintains $400 → $390	Strong Buy	Maintains	$400 → $390	+22.95%	Feb 2, 2026
Andrew Mok Barclays	Barclays	Buy Maintains $404 → $393	Buy	Maintains	$404 → $393	+23.89%	Jan 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

194.80B

Decreased by -2.17%

from 199.13B

Revenue Next Year

200.58B

Increased by 2.97%

from 194.80B

EPS This Year

26.17

Increased by 3.82%

from 25.21

EPS Next Year

29.55

Increased by 12.89%

from 26.17

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	138.64B	156.60B	171.34B	176.81B	199.13B	194.80B	200.58B
Revenue Growth	13.77%	12.95%	9.41%	3.19%	12.62%	-2.17%	2.97%
EPS	24.95	24.28	25.22	25.68	25.21	26.17	29.55
EPS Growth	38.77%	-2.69%	3.87%	1.82%	-1.83%	3.82%	12.89%
Forward PE	-	-	-	-	-	12.12	10.74
No. Analysts	-	-	-	-	-	25	23

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029
High	215.1B	220.5B
Avg	194.8B	200.6B
Low	183.3B	190.4B

Revenue Growth

Revenue Growth	2026	2027	2028	2029
High	8.0%	13.2%
Avg	-2.2%	3.0%
Low	-8.0%	-2.3%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	29.42	33.62
Avg	26.17	29.55
Low	24.90	27.81

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	16.7%	28.5%
Avg	3.8%	12.9%
Low	-1.2%	6.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.